Larimar Therapeutics, Inc. (LRMR)
Total Valuation
LRMR has a market cap or net worth of $149.28 million. The enterprise value is $57.74 million.
| Market Cap | 149.28M |
| Enterprise Value | 57.74M |
Important Dates
The last earnings date was Tuesday, November 14, 2023, before market open.
| Earnings Date | Nov 14, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
LRMR has 43.91 million shares outstanding. The number of shares has increased by 97.51% in one year.
| Shares Outstanding | 43.91M |
| Shares Change (YoY) | +97.51% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 88.96% |
| Float | 20.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.61 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.02, with a Debt / Equity ratio of 0.06.
| Current Ratio | 15.02 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.60% and return on invested capital (ROIC) is -38.77%.
| Return on Equity (ROE) | -32.60% |
| Return on Assets (ROA) | -29.00% |
| Return on Capital (ROIC) | -38.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.28M |
| Employee Count | 26 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.58% in the last 52 weeks. The beta is 0.25, so LRMR's price volatility has been lower than the market average.
| Beta (1Y) | 0.25 |
| 52-Week Price Change | +10.58% |
| 50-Day Moving Average | 3.27 |
| 200-Day Moving Average | 4.02 |
| Relative Strength Index (RSI) | 57.35 |
| Average Volume (30 Days) | 111,790 |
Short Selling Information
The latest short interest is 527,370, so 1.20% of the outstanding shares have been sold short.
| Short Interest | 527,370 |
| Short Previous Month | 576,878 |
| Short % of Shares Out | 1.20% |
| Short % of Float | 2.63% |
| Short Ratio (days to cover) | 5.46 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -38.04M |
| Pretax Income | -33.38M |
| Net Income | -33.38M |
| EBITDA | -33.18M |
| EBIT | -33.38M |
| Earnings Per Share (EPS) | -$0.60 |
Balance Sheet
The company has $96.93 million in cash and $5.39 million in debt, giving a net cash position of $91.54 million or $2.08 per share.
| Cash & Cash Equivalents | 96.93M |
| Total Debt | 5.39M |
| Net Cash | 91.54M |
| Net Cash Per Share | $2.08 |
| Equity / Book Value | 92.71M |
| Book Value Per Share | 2.11 |
| Working Capital | 91.92M |
Cash Flow
| Operating Cash Flow | -30.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | -30.79M |
| FCF Per Share | -$0.70 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LRMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -22.36% |
| FCF Yield | -20.62% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -97.51% |
| Shareholder Yield | -97.51% |
Analyst Forecast
The average price target for LRMR is $11.83, which is 247.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.83 |
| Price Target Difference | 247.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 29, 2020. It was a reverse split with a ratio of 1:12.
| Last Split Date | May 29, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |